Table 2.
Association of the HNF1B/EZH2/ECI2 H-score with the type of lesion, based on 119 patients with prostate lesion. Significant p-values are indicated in bold.
| Type of lesion | N | HNF1B mean ± SD |
HNF1B median |
p-value | EZH2 mean ± SD |
EZH2 median | p-value | ECI2 mean ± SD |
ECI2 median |
p-value |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.925 | < 0.001 | < 0.001 | ||||||||
| PC | 101 | 19.5 ± 36.6 | 0 | 41.8 ± 39.6 | 30 | 156.6 ± 58.8 | 160 | |||
| AH | 18 | 11.7 ± 16.9 | 0 | 5.9 ± 7.7 | 4.5 | 96.1 ± 21.7 | 100 |
PC prostate cancer, AH adenomyomatous hyperplasia.